phase 3 trials ongoing as of 2025 Best phase 2 weight loss (retatrutide) / 24.2% at 48 weeks, 12 mg dose Best phase 3 weight loss (tirzepatide) / 22.5% at 72 weeks, 15 mg dose Combination evidence / zero published controlled trials Primary combination risk / additive nausea, vomiting, potential pancreatitis Switching rationale / inadequate response or tolerability on tirzepatide Guideline position on combining / no major guideline endorses dual-incretin stacking What Are Mounjaro and Retatrutide, and How Do They Differ
It offers clinical evaluation and, when eligible, a prescription that may be routed toward a branded FDA-approved product or a compounded tirzepatide formulation
For instance, studies on the active ingredient in Zepbound for insulin resistance Chicago have demonstrated a dramatic reduction-up to 94%-in the risk of progression from pre-diabetes to full-blown type 2 diabetes over a three-year period
Others want to know if drinking is safe at all during treatment
Research suggests GIP agonism also amplifies the weight loss effects of GLP-1, which explains why dual-agonists like tirzepatide outperform single-agonists like semaglutide
Findings In total, 99 individuals were recruited and invited to complete the three-day food record
